(Bloomberg) - Novavax Inc. tau hais tias muaj kev tsis ntseeg ntau txog nws lub peev xwm nyob hauv kev lag luam mus txog rau xyoo tom ntej, ceeb toom tshiab los ntawm lub tuam txhab tom qab nws tawm tsam los tsim thiab muag tshuaj tiv thaiv Covid-19. Cov khoom lag luam poob rau hauv kev lag luam txuas ntxiv.
Feem ntau Nyeem los ntawm Bloomberg
"Kev tsis txaus ntseeg tseem ceeb" nyob ib puag ncig 2023 cov nyiaj tau los txawm tias yuav tsum muaj nyiaj txaus los pab nyiaj rau kev ua haujlwm, Gaithersburg, Maryland-based kws tsim tshuaj tshuaj tau hais hauv tsab ntawv tshaj tawm hnub Tuesday. Cov lus ceeb toom tuaj raws li lub tuam txhab tau tshaj tawm txog kev poob rau peb lub hlis twg yuav luag ob zaug dav li cov kws tshuaj ntsuam tau kwv yees.
"Vim tias qhov tsis paub tseeb no, muaj kev tsis ntseeg ntau txog peb lub peev xwm mus txuas ntxiv raws li kev txhawj xeeb," lub tuam txhab tau hais.
Shares ntawm Novavax poob 25% thaum 6:35 teev tsaus ntuj hauv New York hauv kev ua lag luam lig. Cov khoom lag luam poob 10% xyoo no txog hnub Tuesday kaw, txuas ntxiv 93% muag rau 2022.
Novavax tau tshaj tawm kev muag khoom ntawm $ 357 lab lub quarter dhau los, piv nrog qhov kwv yees nruab nrab ntawm $ 380.3 lab sau los ntawm Bloomberg. Lub tuam txhab tau tshaj tawm qhov poob ntawm $ 2.28 ib feem, ntau dua li Wall Street qhov kev cia siab ntawm qhov poob ntawm $ 1.15 ib feem. Nws xaus lub quarter nrog $ 1.34 nphom nyiaj ntsuab thiab sib npaug.
Cov teeb meem kev tsim khoom tau ncua sij hawm lub tuam txhab kev tswj hwm kev xa tawm rau nws cov tshuaj tiv thaiv Covid-19. Txog lub sijhawm Novavax tau txais kev tso cai rau nws cov tshuaj tua kab mob protein ntau xyoo tas los, cov tshuaj tiv thaiv mRNA los ntawm Moderna Inc. thiab Pfizer Inc. twb tau ua lag luam. Novavax tam sim no pom nws tus kheej sim muag nws cov kev txhaj tshuaj raws li tsoomfwv Meskas tau npaj kom tsis txhob yuav cov tshuaj tiv thaiv Covid thiab tsis txhob cia lub luag haujlwm ntawd hloov mus rau kev lag luam ntiag tug.
Txog niaj hnub no, Novavax tau xa 1.1 lab koob tshuaj ntawm nws cov tshuaj tiv thaiv Covid hauv Asmeskas, ib feem me me ntawm kwv yees li 650 lab los ntawm Pfizer thiab 400 lab los ntawm Moderna, raws li cov ntaub ntawv los ntawm Lub Chaw Tiv Thaiv thiab Tiv Thaiv Kab Mob.
Tsoomfwv UK tau txiav nws daim ntawv cog lus nrog Novavax thaum Lub Kaum Ob Hlis, xa cov shares poob 34%. Lub tuam txhab tau hais tias nws tab tom nrhiav kev ncaj ncees thiab nuj nqis ntxiv.
(Hloov tshiab nrog lub tuam txhab nqe lus thiab cov ntsiab lus ntxiv los ntawm kab lus thib peb)
Feem ntau Nyeem los ntawm Bloomberg Businessweek
© 2023 Bloomberg LP
Tau qhov twg los: https://finance.yahoo.com/news/novavax-falls-citing-substantial-doubt-213338302.html